Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?

Volume: 39, Issue: 10, Pages: 883 - 890
Published: Oct 1, 2016
Abstract
The role of patients as key contributors in pharmacovigilance was acknowledged in the new EU pharmacovigilance legislation. This contains several efforts to increase the involvement of the general public, including making patient adverse drug reaction (ADR) reporting systems mandatory. Three years have passed since the legislation was introduced and the key question is: does pharmacovigilance yet make optimal use of patient-reported safety...
Paper Details
Title
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
Published Date
Oct 1, 2016
Volume
39
Issue
10
Pages
883 - 890
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.